Literature DB >> 27504067

An Annual Formulary Review Strategy Implemented by a Saudi Health System.

Laila Carolina Abu Esba.   

Abstract

As in the U.S., there is no unified national formulary in Saudi Arabia, so individual institutions must develop their own medication lists. A Saudi health system's strategy for maintaining formulary safety, efficacy, and cost-effectiveness is described.

Entities:  

Year:  2016        PMID： 27504067      PMCID： PMC4959619     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  5 in total

1.  Total formulary review--the easy way.

Authors:  K Chase; J D Meyer; W N Kelly
Journal:  Hosp Pharm       Date:  1984-03

2.  Formulary evaluation using a class review approach: experience and results from an academic medical center.

Authors:  Emily L Persson; Katherine S Miller; Jennifer A Nieman; Angela P Sgourakis; Shawn R Akkerman
Journal:  P T       Date:  2013-04

3.  ASHP guidelines on medication cost management strategies for hospitals and health systems.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2008-07-15       Impact factor: 2.637

4.  ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.

Authors:  Linda S Tyler; Sabrina W Cole; J Russell May; Mirta Millares; Michael A Valentino; Lee C Vermeulen; Andrew L Wilson
Journal:  Am J Health Syst Pharm       Date:  2008-07-01       Impact factor: 2.637

5.  National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool.

Authors:  Azuana Ramli; Syed Mohamed Aljunid; Saperi Sulong; Faridah Aryani Md Yusof
Journal:  Ther Clin Risk Manag       Date:  2013-12-04       Impact factor: 2.423
  5 in total
  1 in total

1.  P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.

Authors:  Laila Carolina Abu Esba; Hind Almodaimegh; Ali Alhammad; Mazen Ferwana; Consuela Yousef; Sherine Ismail
Journal:  P T       Date:  2018-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.